萨西图祖马布可治疗激素受体阳性HER2阴性晚期乳腺癌
Laia Garrigos1, Daniela Camacho1, José Manuel Perez-Garcia1,2
1International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Hospital, Barcelona, Spain.
Expert review of anticancer therapy
|August 30, 2024
概括
在其他疗法失败后,Sacituzumab govitecan (SG) 为晚期HR+/HER2乳腺癌提供了一种新的治疗方法. 这种抗体-药物联合体显示出有效性和可控的副作用,改善了患者的选择.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 激素受体阳性 (HR+) /人表皮生长因子受体2阴性 (HER2-) 晚期乳腺癌 (ABC) 治疗通常涉及内分泌疗法 (ET) 和向药物.
- 在ET失败后,化疗 (ChT) 是主要的选择,这构成了治疗挑战.
- 抗体-药物联合体 (ADC) 已成为ABC的新型治疗替代品.
研究的目的:
- 审查Sacituzumab govitecan (SG) 在HR+/HER2-ABC的临床疗效和安全性.
- 评估SG对在内分泌治疗 (ET) 和化疗 (ChT) 后进展的患者的影响.
- 为了比较SG的结果与传统的ChT.
主要方法:
- 审查最近的临床试验,包括I/II期和III期研究.
- 文献搜索侧重于临床结果,疗效和安全性.
- 萨西图祖马布 (SG) 与化疗 (ChT) 的比较.
主要成果:
- 萨西图祖马布戈维特干 (SG) 在HR+/HER2-ABC后ET和循环素依赖性激酶4/6抑制剂 (CDKi) 中有效,并且至少经过两次ChT疗程后有效.
- SG显示出可管理的毒性概况.
- SG代表了这种患者群体的治疗选择的重大进步.
结论:
- 萨西图祖马布戈维特康 (SG) 是一种有效的治疗方法,用于先进的HR+/HER2-乳腺癌患者,这些患者在先前的治疗中进展.
- 需要进一步的研究来优化SG的使用,并确认长期益处.
- SG提供了一种有价值的新疗法选择,改善了HR+/HER2-ABC的治疗环境.
更多相关视频
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.6K
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.7K
相关概念视频
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:30Cancer Vaccines
347
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
154
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
154